3'H-CYCLOPROPA(6,7)PREGNA-1,4,6-TRIENE-3,20-DIONE, 3',3'-DIFLUORO-6.BETA.,7.BETA.-DIHYDRO-11.BETA.,21-DIHYDROXY-16.ALPHA.-METHYL-, 21-ACETATE
UNII WN4H9P4H2P
Substance Identification & Data
This profile provides standardized clinical and technical data for 3'h-cyclopropa(6,7)pregna-1,4,6-triene-3,20-dione, 3',3'-difluoro-6.beta.,7.beta.-dihydro-11.beta.,21-dihydroxy-16.alpha.-methyl-, 21-acetate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WN4H9P4H2P.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 23139-46-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C25H30F2O5 BXADDOYDYDPWEB-BSWZIWPKSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 3'h-cyclopropa(6,7)pregna-1,4,6-triene-3,20-dione, 3',3'-difluoro-6.beta.,7.beta.-dihydro-11.beta.,21-dihydroxy-16.alpha.-methyl-, 21-acetate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.